-
倍他米松二丙酸酯杂质A
- names:
Betamethasone Dipropionate EP Impurity A
- CAS号:
378-44-9
MDL Number: - MF(分子式): C22H29FO5 MW(分子量): 392.46
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YPZZ62576-10mg | 10mg | 0.98 | ¥ 0.00 | ¥ 0.00 | Get quote | ¥ 0.00 |
| 中文别名 | 倍他米松杂质 |
| 英文别名 | (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
| CAS号 | 378-44-9 |
| Inchi | InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1CopyCopied |
| InchiKey | UREBDLICKHMUKA-DVTGEIKXSA-NCopyCopied |
| 分子式 Formula | C22H29FO5 |
| 分子量 Molecular Weight | 392.46 |
| 溶解度Solubility | |
| 性状 | |
| 储藏条件 Storage conditions |
杂质产品注意事项:1、普通杂质产品需要提供核磁[氢谱、碳谱(如氢谱不能证明该化合物的情况下)]、LC-MS图谱、色谱图、手性化合物需要核磁二维图谱表征。
| 产品说明 | 倍他米松二丙酸酯 EP 杂质 A是合成倍他米松二丙酸酯 过程中产生多余的化学物质它会与药物活性成分(API)一起保留,这些有害化学物质的存在,可能影响药品的功效和安全性。 |
| Introduction | Betamethasone Dipropionate EP Impurity A is a impurity of Betamethasone Dipropionate . It will remain with the active pharmaceutical ingredients (API). The presence of these harmful chemicals may affect the efficacy and safety of the drug. |
| Application1 | |
| Application2 | |
| Application3 |
| 警示图 | |
| 危险性 | |
| 危险性警示 | 暂无数据 |
| 安全声明 | CAUTION: May irritate eyes, skin |
| 安全防护 | |
| 备注 |
| HPLC Separation of Estradiol on Phenomemenx Onyx C18 with UV DetectionHPLC of Cortisone Acetate on Phenomenex Gemini 5u C18 with UV detectionReduced ion mobilities of aspartame, cortisone, betamethasone, butylparaben, propylparaben and vanillin,International Journal for Ion Mobility Spectrometry[DOI: 10.1007s12127-017-0216-9] |
| The adrenal gland of newt Triturus carnifex (Amphibia, Urodela) following in vivo betamethasone administration,Anatomy and Embryology[DOI: 10.1007s00429-006-0096-y] |
| Tumorangiogenese und Immunsuppression,Mund-, Kiefer- und Gesichtschirurgie[DOI: 10.1007s10006-005-0635-3] |
| Lornoxicam injection is inferior to betamethasone in the treatment of subacromial impingement syndrome,Der Orthopde[DOI: 10.1007s00132-016-3302-5] |
| Corticosteroids do not alter mucosal permeability after subclinical intestinal ischemia-reperfusion injury in the rat,Pediatric Surgery International[DOI: 10.1007BF00176114] |
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


